Form 4: Elanco Executive Rajeev Modi Boosts Stake with Deferred Stock Unit Acquisition

Sentiment:

Insider Transaction Report


Rajeev A. Modi, Executive Vice President at Elanco Animal Health Inc., acquired 102.4345 deferred stock units, increasing his direct beneficial ownership in the company.

Better than expectedThe acquisition of additional deferred stock units by a key executive suggests confidence in the company's future performance and aligns management's interests with those of shareholders.

Summary

  • Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation for Elanco Animal Health Inc. (ELAN), reported an acquisition of deferred stock units.
  • The transaction occurred on June 13, 2025, involving the acquisition of 102.4345 Deferred Stock Units (DSUs).
  • Each DSU represents the right to receive one share of Elanco common stock or its cash equivalent.
  • The DSUs were acquired at a price of $13.81 per unit.
  • Following this transaction, Mr. Modi directly beneficially owns a total of 6,361.6966 Deferred Stock Units.
  • These DSUs are set to settle in cash or shares of Company common stock upon termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: The acquisition of additional deferred stock units by a key executive indicates a positive sentiment and alignment of interests with shareholders, suggesting confidence in the company's future.

Positives

  • The acquisition of additional deferred stock units by a key executive, Rajeev A. Modi, indicates continued alignment of management interests with shareholder value and potential confidence in the company's future performance.

Future Outlook

NA

Industry Context

This filing is specific to Elanco Animal Health Inc. and details an individual executive's stock acquisition, thus it does not provide broader industry context or trends.

Stakeholder Impact

  • Shareholders may view this acquisition as a positive signal, indicating management's confidence in the company's long-term prospects and a commitment to aligning executive incentives with shareholder returns.

Key Dates

DateDescription
06/13/2025Date of the reported transaction (acquisition of Deferred Stock Units).
06/17/2025Date the Form 4 filing was signed and submitted to the SEC.

Recommendation

hold

Keywords

Elanco Animal Health Inc., ELAN, Form 4, Insider Transaction, Deferred Stock Units, Executive Compensation, Stock Acquisition, Rajeev A. Modi

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.